Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: The Hisayama study

Allergology International

Volumn 64, Issue 1, 2015, Pages 49-53

  Tsukuya, Go ^a,b   Matsumoto, Koichiro ^b   Fukuyama, Satoru ^b   Crawford, Bruce ^c   Nakanishi, Yoichi ^b   Ichinose, Masakazu ^d   Machida, Kentaro ^a   Samukawa, Takuya ^a   Ninomiya, Toshiharu ^b   Kiyohara, Yutaka ^b   Inoue, Hiromasa ^a,b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c ADELPHI REAL WORLD   (United Kingdom)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Pulmonary function tests; Questionnaires; Screening

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE POPULATION SCREENER SCORE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; JAPANESE (PEOPLE); LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPIROMETRY; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; HEALTH SURVEY; JAPAN; LUNG FUNCTION TEST; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUE; REPRODUCIBILITY; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; ROC CURVE; SPIROMETRY; SURVEYS AND QUESTIONNAIRES;

EID: 84952329989     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2014.06.002     Document Type: Article

References (24)

1. 1. Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2013 Available from: http://www.goldcopd.org/.
2. 2. World Health Organization. World Health Statistics. 2008 Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf.
3. 3. Buist, A.S., McBurnie, M.A., Vollmer, W.M., Gillespie, S., Burney, P., Mannino, D.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370 (2007), 741–750.
4. 4. Menezes, A.M., Perez-Padilla, R., Jardim, J.R., Muiño, A., Lopez, M.V., Valdivia, G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (2005), 1875–1881.
5. 5. Fukuchi, Y., Nishimura, M., Ichinose, M., Adachi, M., Nagai, A., Kuriyama, T., et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 9 (2004), 458–465.
6. 6. Qaseem, A., Snow, V., Shekelle, P., Sherif, K., Wilt, T.J., Weinberger, S., et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 147 (2007), 633–638.
7. 7. Hvidsten, S.C., Storesund, L., Wentzel-Larsen, T., Gulsvik, A., Lehmann, S., Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J 4 (2010), 13–21.
8. 8. Miravitlles, M., Soriano, J.B., Garcia-Rio, F., Muñoz, L., Duran-Tauleria, E., Sanchez, G., et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64 (2009), 863–868.
9. 9. Enright, P., Does screening for COPD by primary care physicians have the potential to cause more harm than good?. Chest 129 (2006), 833–835.
10. 10. Qaseem, A., Wilt, T.J., Weinberger, S.E., Hanania, N.A., Criner, G., van der Molen, T., et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155 (2011), 179–191.
11. 11. Bellamy, D., Bouchard, J., Henrichsen, S., Johansson, G., Keenan, J., Langhammeret, A., et al. Chronic airways diseases. A guide for primary care physicians. IPAG Diagnosis and Management Handbook, 2005, Edgewater: MCR Vision.
12. 12. Price, D.B., Tinkelman, D.G., Halbert, R.J., Nordyke, R.J., Isonaka, S., Nonikov, D., et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 73 (2006), 285–295.
13. 13. Price, D.B., Tinkelman, D.G., Nordyke, R.J., Isonaka, S., Halbert, R.J., COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 129 (2006), 1531–1539.
14. 14. van Schayck, C.P., Halbert, R.J., Nordyke, R.J., Isonaka, S., Maroni, J., Nonikov, D., Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 10 (2005), 323–333.
15. 15. Van Schayck, C.P., Loozen, J.M., Wagena, E., Akkermans, R.P., Wesseling, G.J., Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ, 324, 2002, 1370.
16. 16. Martinez, F.J., Raczek, A.E., Seifer, F.D., Conoscenti, C.S., Curtice, T.G., D'Eletto, T., et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 5 (2008), 85–95.
17. 17. Chan, J.C., Malik, V., Jia, W., Kadowaki, T., Yajnik, C.S., Yoon, K.H., et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301 (2009), 2129–2140.
18. 18. Hirakawa, Y., Ninomiya, T., Mukai, N., Doi, Y., Hata, J., Fukuhara, et al. Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol 176 (2012), 856–864.
19. 19. The Committee of Pulmonary Physiology. The Japanese Respiratory Society. [Guidelines for Pulmonary Function Tests: Spirometry, Flow-Volume Curve, Diffusion Capacity of the Lung]. Tokyo, 2004 (in Japanese).
20. 20. World Health Organization. Process of translation and adaptation of instruments. Available from: http://www.who.int/substance_abuse/research_tools/translation/en/.
21. 21. Bayes, T., Price, R., An Essay towards solving a Problem in the Doctrine of Chance. By the late Rev. Mr. Bayes, communicated by Mr. Price, in a letter to John Canton M. A. and F. R. S. Philos Trans R Soc Lond 53 (1763), 370–418.
22. 22. Behrendt, C.E., Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 128 (2005), 1239–1244.
23. 23. Salvi, S.S., Barnes, P.J., Chronic obstructive pulmonary disease in non-smokers. Lancet 374 (2009), 733–743.
24. 24. Zhou, Y., Wang, C., Yao, W., Chen, P., Kang, J., Huang, S., et al. COPD in Chinese nonsmokers. Eur Respir J 33 (2009), 509–518.